IRIS
CAPODANNO, DAVIDE FRANCESCO MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.889
EU - Europa 6.528
AS - Asia 6.293
SA - Sud America 1.102
AF - Africa 590
Continente sconosciuto - Info sul continente non disponibili 16
OC - Oceania 7
Totale 29.425
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.161
SG - Singapore 3.132
CN - Cina 2.403
IE - Irlanda 1.914
UA - Ucraina 1.776
IT - Italia 1.107
BR - Brasile 1.024
CA - Canada 673
RU - Federazione Russa 538
CI - Costa d'Avorio 459
SE - Svezia 291
VN - Vietnam 215
GR - Grecia 193
KR - Corea 156
GB - Regno Unito 144
DE - Germania 130
IN - India 90
FI - Finlandia 64
FR - Francia 61
CH - Svizzera 60
SN - Senegal 59
AT - Austria 51
UZ - Uzbekistan 48
NL - Olanda 45
PL - Polonia 42
IQ - Iraq 37
TR - Turchia 36
BD - Bangladesh 35
HK - Hong Kong 34
MX - Messico 29
AR - Argentina 26
BE - Belgio 26
ZA - Sudafrica 25
JP - Giappone 24
ES - Italia 23
NG - Nigeria 16
EU - Europa 15
VE - Venezuela 15
EC - Ecuador 14
MA - Marocco 13
PK - Pakistan 13
CZ - Repubblica Ceca 12
BG - Bulgaria 9
CO - Colombia 9
LB - Libano 9
KE - Kenya 8
AE - Emirati Arabi Uniti 6
AZ - Azerbaigian 6
JM - Giamaica 6
JO - Giordania 6
LT - Lituania 6
NP - Nepal 6
PH - Filippine 6
AL - Albania 5
BY - Bielorussia 5
PA - Panama 5
CR - Costa Rica 4
EG - Egitto 4
PE - Perù 4
RO - Romania 4
RS - Serbia 4
SA - Arabia Saudita 4
BH - Bahrain 3
BO - Bolivia 3
GE - Georgia 3
HN - Honduras 3
ID - Indonesia 3
KZ - Kazakistan 3
MY - Malesia 3
NZ - Nuova Zelanda 3
OM - Oman 3
PT - Portogallo 3
PY - Paraguay 3
SI - Slovenia 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
AU - Australia 2
IL - Israele 2
IR - Iran 2
MK - Macedonia 2
SK - Slovacchia (Repubblica Slovacca) 2
TN - Tunisia 2
TV - Tuvalu 2
AF - Afghanistan, Repubblica islamica di 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BZ - Belize 1
CG - Congo 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
ET - Etiopia 1
GY - Guiana 1
HU - Ungheria 1
IS - Islanda 1
LC - Santa Lucia 1
LU - Lussemburgo 1
MD - Moldavia 1
NE - Niger 1
Totale 29.418
Salva come PNG Salva come JPEG
Città #
Jacksonville 2.344
Santa Clara 2.017
Dublin 1.911
Singapore 1.862
Chandler 1.363
Boardman 922
Nanjing 637
Houston 621
Lawrence 535
Andover 530
Cambridge 529
Toronto 498
Abidjan 459
Ashburn 449
Chicago 428
Catania 396
Hefei 374
Des Moines 372
Dallas 360
Nanchang 227
San Mateo 227
Civitanova Marche 201
Wilmington 186
Hebei 173
Seoul 156
Shenyang 151
Dong Ket 141
Athens 136
Ottawa 134
Beijing 125
Los Angeles 123
Jiaxing 115
Tianjin 113
Saint Petersburg 112
Changsha 88
São Paulo 83
Milan 67
Dakar 59
Washington 56
Moscow 52
Council Bluffs 46
Seattle 45
Rome 44
Brooklyn 43
Lappeenranta 43
Bremen 41
Norwalk 40
Hangzhou 38
Hanoi 33
Kunming 33
Hong Kong 32
Jinan 32
Rio de Janeiro 32
Ningbo 29
Pune 29
Belo Horizonte 27
New York 27
Brussels 26
San Francisco 26
Columbus 24
Den Haag 24
Phoenix 24
Liberty Lake 23
The Dalles 23
Warsaw 23
Zhengzhou 23
Palermo 22
Boston 21
Stockholm 21
Helsinki 19
Montreal 19
Gravina di Catania 18
Porto Alegre 18
Abuja 16
Brasília 16
Edinburgh 16
Ho Chi Minh City 16
Munich 16
Taizhou 16
Tokyo 16
Ann Arbor 15
Atlanta 15
Campinas 15
Curitiba 15
Tashkent 15
Guangzhou 14
Charlotte 13
Frankfurt Am Main 13
Guarulhos 13
Johannesburg 13
London 13
Padova 13
Pozzo Di Gotto 13
Falls Church 12
Manduria 12
Mexico City 11
Ribeirão Preto 11
Salvador 11
Secaucus 11
Shanghai 11
Totale 20.671
Salva come PNG Salva come JPEG
Nome #
Novel oral anticoagulants versus warfarin in non-valvular atrial fibrillation: A meta-analysis of 50,578 patients 520
Neoatherosclerosis as the cause of late failure of a bioresorbable vascular scaffold 229
1-Year Outcomes of Everolimus-Eluting Bioresorbable Scaffolds versus Everolimus-Eluting Stents: a Propensity Matched Comparison of the GHOST-EU and XIENCE V USA Registries 158
A Risk Model for Prediction of One-Year Mortality in Patients Undergoing MitraClip Implantation 137
Incorporating glomerular filtration rate or creatinine clearance by the modification of diet in renal disease equation or the Cockcroft-Gault equations to improve the global accuracy of the Age, Creatinine, Ejection Fraction [ACEF] score in patients undergoing percutaneous coronary intervention 131
[Management of severe stenosis controversies and promises] 102
A Multidisciplinary Approach on the Perioperative Antithrombotic Management of Patients With Coronary Stents Undergoing Surgery: Surgery After Stenting 2 101
Platelet function profiles in the elderly: Results of a pharmacodynamic study in patients on clopidogrel therapy and effects of switching to prasugrel 5 mg in patients with high platelet reactivity. 100
A focused update on emerging prognostic determinants in distal left main percutaneous coronary intervention 99
A novel approach to define risk of stent thrombosis after percutaneous coronary intervention with drug-eluting stents: the DERIVATION score 99
SYNTAX Score II predicts carotid disease in a multivessel coronary disease population 98
Anatomical features and management of bioresorbable vascular scaffolds failure: A case series from the GHOST registry. 95
A comparison between Endeavor and Endeavor Resolute drug-eluting stents: outcome at six months follow up 95
Prevalence of renal artery stenosis in patients undergoing cardiac catheterization 94
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC)Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC) 94
Miocardio non compattato del ventricolo sinistro e aneurisma del setto interatriale con difetto. Associazione casuale? 90
Effect of post-procedural evidence-based therapy on 2-year prognosis after transcatheter mitral valve repair 87
Temporal patterns of early neointimal strut coverage of the CATANIA stent compared with drug eluting stents and bare metal stent: the Rapid Evaluation of Vessel Healing after Angioplasty (REVEAL) trial 86
Incidence, Timing, Causes and Predictors of Early and Late Re-Hospitalization in Patients Who Underwent Percutaneous Mitral Valve Repair With the MitraClip System 86
A simple risk tool (the OBSERVANT score) for prediction of 30-day mortality after transcatheter aortic valve replacement. 85
Clinical Outcomes Following Intravascular Imaging-Guided Versus Coronary Angiography-Guided Percutaneous Coronary Intervention With Stent Implantation: A Systematic Review and Bayesian Network Meta-Analysis of 31 Studies and 17,882 Patients 85
A comparison between Endeavor and Endeavor Resolute drug-eluting coronary stents: outcomes at six month follow up 85
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC) Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC) 85
A post-hoc analysis of the CUSTOMIZE Registry on the differential impact of EuroSCORE and SYNTAX score in Left Main Patients with Intermediate Global Risk 84
A novel 3-d reconstruction system for the assessment of bifurcation lesions treated by the mini-crush technique 84
Coronary Angiography, Intravascular Ultrasound, and Optical Coherence Tomography in the Guidance of Percutaneous Coronary Intervention: A Systematic Review and Network Meta-Analysis. 83
Recent acquisitions and advances in the knowledge of coronary flow disturbances after percutaneous coronary intervention 83
The treatment of coronary bifurcation lesions with bioresorbable vascular scaffolds 82
Pharmacological and Clinical Appraisal of Factor XI Inhibitor Drugs. 81
Pre-Defining Optimal C-Arm Position for TAVI With CT-Scan Using a Free Software 81
Optimized Screening of Coronary Artery Disease With Invasive Coronary Angiography and Ad Hoc Percutaneous Coronary Intervention During Transcatheter Aortic Valve Replacement 81
Intraoperative defibrillation threshold testing durino implantable cardioverter-defibrillator insertion: Do we really need it? 80
A Multidisciplinary Consensus Document on Follow-up Strategies for Patients Treated with Percutaneous Coronary Intervention 80
Incidence of Long-Term Structural Valve Dysfunction and Bioprosthetic Valve Failure After Transcatheter Aortic Valve Replacement 80
Diabetes mellitus: the scary killer haunting silently 79
Cigarette Smoking is Associated with a Dose-Response Effect in Clopidogrel Treated Patients with Diabetes Mellitus and Coronary Artery Disease: Results of a Pharmacodynamic Study 79
Acute Left Atrial Spontaneous Echo Contrast and Suspicious Thrombus Formation Following Mitral Regurgitation Reduction With The MitraClip System 79
Antithrombotic Therapy for Primary and Secondary Prevention of Ischemic Stroke : JACC State-of-the-Art Review 78
Antithrombotic Therapy in Patients with Chronic Kidney Disease 78
Computing Methods for Composite Clinical Endpoints in Unprotected Left Main Coronary Artery Revascularization: A Post Hoc Analysis of the DELTA Registry 78
Acute Kidney Injury With the RenalGuard System in Patients Undergoing Transcatheter Aortic Valve Replacement: The PROTECT-TAVI Trial (PROphylactic effecT of furosEmide-induCed diuresis with matched isotonic intravenous hydraTion in Transcatheter Aortic Valve Implantation) 78
Predictive Accuracy of CHA2DS2-VASc and HAS-BLED Scores In Patients Without Atrial Fibrillation Undergoing Percutaneous Coronary Intervention And Discharged On Dual Antiplatelet Therapy 78
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice 78
Antithrombotic Therapy for Secondary Prevention in Patients with Cerebrovascular Disease 77
Association of Tricuspid Regurgitation With Clinical and Echocardiographic Outcomes After Percutaneous Mitral Valve Repair With the MitraClip System: Thirty-Day and Twelve-Month Follow-up From the GRASP Registry 77
Clinical implication of different plaque distribution patterns in distal left main coronary artery 77
Prevention of Acute Kidney Injury with the RenalGuard System in patients undergoing Transcatheter Aortic Valve Implantation: The PROTECT-TAVI trial 77
Early discharge in acute myocardial infarction after clinical and angiographic risk assessment 76
Three-Dimensional Angle Assessment and Plaque Distribution Classification in Left Main Disease: Impact of Geometry on Outcome 76
Tailoring duration of DAPT with risk scores 76
Very Late Outcomes of Drug-Eluting Stents: The "Catch-Down" Phenomenon 76
Extended use of percutaneous edge-to-edge mitral valve repair beyond EVEREST (Endovascular Valve Edge-to-Edge Repair) criteria: 30-day and 12-month clinical and echocardiographic outcomes from the GRASP (Getting Reduction of Mitral Insufficiency by Percutaneous Clip Implantation) registry. 76
Vascular response and healing profile of everolimus-eluting bioresorbable vascular scaffolds for percutaneous treatment of chronic total coronary occlusions: A one-year optical coherence tomography analysis from the GHOST-CTO registry 76
Long-term clinical and echocardiographic outcomes of Mitraclip therapy in patients nonresponders to cardiac resynchronization 76
2021 ESC/EACTS Guidelines for the management of valvular heart disease 76
Long-Term Follow-Up after Drug Eluting Stent Implantation in Left Main Trifurcations 75
Cyphering the mechanism of late failure of bioresorbable vascular scaffolds in percutaneous coronary intervention of the left main coronary artery 75
Upcoming TAVI trials: rationale, design and likely impact on clinical practice 74
Bioresorbable vascular scaffold in patients with complex coronary artery disease. 74
Feasibility and Predictors of Early Discharge After Percutaneous Edge-to-Edge Mitral Valve Repair 74
Standardised Definitions of Structural Deterioration and Valve Failure in Assessing Long-Term Durability of Transcatheter and Surgical Aortic Bioprosthetic Valves: A Consensus Statement from The European Association of Percutaneous Cardiovascular Interventions (EAPCI) endorsed by the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) 74
Comparison of suture-based vascular closure devices in transfemoral transcatheter aortic valve implantation. 74
Transcatheter aortic valve implantation in 2017: state of the art 74
Mechanisms, Pathophysiology, and Clinical Aspects of Incomplete Stent Apposition 73
Usefulness of 3D OCT to Diagnose a Noncircumferential Open-Cell Stent Fracture 73
Reply: Validity of Randomized Trials Comparing Radial Versus Femoral Access in Acute Coronary Syndrome 73
Early, late and very late incidence of bioresorbable scaffold thrombosis: a systematic review and meta-analysis of randomized clinical trials and observational studies 73
Quality of life assessment after percutaneous aortic valve implantation 73
Local delivery versus intracoronary infusion of abciximab in patients with acute coronary syndromes 73
Is the metallic stent a safe treatment for bioresorbable scaffold failure? Insights from optical coherence tomography 73
The year in cardiology 2017: coronary interventions 73
Long-term clinical outcomes after percutaneous coronary intervention versus coronary artery bypass grafting for ostial/midshaft lesions in unprotected left main coronary artery from the DELTA registry: a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment. 73
2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes 73
Mini-crush versus T-provisional techniques in bifurcation lesions: clinical and angiographic long term outcome after implantation of drug–eluting stents 72
EuroSCORE refines the predictive ability of SYNTAX score in patients undergoing left main percutaneous coronary intervention 72
Haemostatic Profiles Assessed by Thromboelastography in Patients with End-Stage Renal Disease 72
The inflammatory abdominal aortic aneurysm and coronary artery disease. Case report and review 72
CORONARY REMODELLING AFTER RECANALIZATION OF CHRONIC TOTAL OCCLUSION 72
Long-term bleeding events in patients with prolonged dual antiplatelet therapy after DES implantation 72
Pretreatment with Antiplatelet Agents in the Setting of Percutaneous Coronary Intervention: When and Which Drugs? 71
Effects of Cangrelor in Coronary Artery Disease Patients With and Without Diabetes Mellitus: An In Vitro Pharmacodynamic Investigation 71
Late Self-Apposition With One-Year Persisting Uncoverage of Malapposed Bioresorbable Polymeric Struts 71
Spontaneous coronary artery dissection 70
Reply: plaque rupture in stable coronary artery disease 70
Management issues of chronic therapy with non-vitamin K oral anticolagulants or antiplatelet agents: different or alike? 70
Emerging strategies for rapid reversal of anticoagulation in patients undergoing catheter-based interventions: aptamers enter the RADAR 70
New-onset coronary aneurism and late-acquired incomplete scaffold apposition after full polymer jacket of a chronic total occlusion with bioresorbable scaffolds 70
Functional profile of the platelet P2Y12 receptor signaling pathway in patients with diabetes mellitus and coronary artery disease 70
Antithrombotic pharmacotherapy after transcatheter aortic valve implantation: an update 70
Coronary revascularization strategies in patients with multivessel disease: is it all about diabetes? 70
Assessment of Noninferiority Margins in Cardiovascular Medicine Trials 69
Impact of race and gender on antithrombotic therapy 69
Bivalirudin For Acute Coronary Syndromes: Premises, Promises and Doubts 69
Risk stratification after ST-elevation myocardial infarction 69
Optimal P2Y12 inhibitor for primary PCI in STEMI: Network meta-analysis in the data-fre zone. Do you believe in magic? 69
Update on clinical evidence (Part II): a summary of the main post market studies 69
Volumetric Assessment of Lesion Severity with Optical Coherence Tomography: Relationship with Fractional Flow Reserve 69
Fate of Non-Culprit Plaques in Patients With ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention Followed by Statin Therapy: A Serial Optical Coherence Tomography Analysis From the OCTAVIA Study 69
Decision Analytic Markov Model Weighting Expected Benefits and Current Limitations of First-Generation Bioresorbable Vascular Scaffolds: Implications for Manufacturers and Next Device Iterations 69
Suitability for elderly with heart disease of a QR code-based feedback of drug intake: Overcoming limitations of current medication adherence telemonitoring systems 68
Totale 8.579
Salva come PNG Salva come JPEG
Categoria #
all - tutte 121.571
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 121.571
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.965 0 0 492 7 821 112 495 6 264 24 518 226
2021/20223.761 494 579 11 50 618 12 558 99 331 5 83 921
2022/20235.180 545 67 40 349 671 985 9 814 1.432 34 172 62
2023/20242.393 125 494 111 192 100 372 50 104 17 79 472 277
2024/20258.376 96 1.246 605 325 1.999 674 153 360 706 968 450 794
2025/20262.121 1.039 914 168 0 0 0 0 0 0 0 0 0
Totale 30.193